Budesonide-induced acute hepatitis in an HIV-positive patient with ritonavir as a co-medication

被引：9

作者：

Sagir, A ^{[1
]}

Wettstein, M ^{[1
]}

Oette, M ^{[1
]}

Erhardt, A ^{[1
]}

Häussinger, D ^{[1
]}

机构：

[1] Univ Klinikum Dusseldorf, Klin Gastroenterol Hepatol & Infektiol, D-40225 Dusseldorf, Germany

来源：

AIDS | 2002年 / 16卷 / 08期

关键词：

D O I：

10.1097/00002030-200205240-00017

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1191 / 1192

页数：2

共 10 条

[1]

DANIELSSON A, 1994, ALIMENT PHARM THERAP, V8, P585

[2] A SHORT-TERM STUDY OF THE SAFETY, PHARMACOKINETICS, AND EFFICACY OF RITONAVIR, AN INHIBITOR OF HIV-1 PROTEASE [J].

DANNER, SA ;

CARR, A ;

LEONARD, JM ;

LEHMAN, LM ;

GUDIOL, F ;

GONZALES, J ;

RAVENTOS, A ;

RUBIO, R ;

BOUZA, E ;

PINTADO, V ;

AGUADO, AG ;

DELOMAS, JG ;

DELGADO, R ;

BORLEFFS, JCC ;

HSU, A ;

VALDES, JM ;

BOUCHER, CAB ;

COOPER, DA ;

GIMENO, C ;

CLOTET, B ;

TOR, J ;

FERRER, E ;

MARTINEZ, PL ;

MORENO, S ;

ZANCADA, G ;

ALCAMI, J ;

NORIEGA, AR ;

PULIDO, F ;

GLASSMAN, HN .

NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (23) :1528-1533

[3] HIV protease inhibitors, saquinavir, indinavir and ritonavir: Inhibition of CYP3A4-mediated metabolism of testosterone and binzoxazinorifamycin, KRM-1648, in human liver microsomes [J].

Inaba, T ;

Fischer, NE ;

Riddick, DS ;

Stewart, DJ ;

Hidaka, T .

TOXICOLOGY LETTERS, 1997, 93 (2-3) :215-219

[4]

JONSSON G, 1995, DRUG METAB DISPOS, V23, P137

[5] ABT-538 IS A POTENT INHIBITOR OF HUMAN-IMMUNODEFICIENCY-VIRUS PROTEASE AND HAS HIGH ORAL BIOAVAILABILITY IN HUMANS [J].

KEMPF, DJ ;

MARSH, KC ;

DENISSEN, JF ;

MCDONALD, E ;

VASAVANONDA, S ;

FLENTGE, CA ;

GREEN, BE ;

FINO, L ;

PARK, CH ;

KONG, XP ;

WIDEBURG, NE ;

SALDIVAR, A ;

RUIZ, L ;

KATI, WM ;

SHAM, HL ;

ROBINS, T ;

STEWART, KD ;

HSU, A ;

PLATTNER, JJ ;

LEONARD, JM ;

NORBECK, DW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2484-2488

[6]

Kumar GN, 1996, J PHARMACOL EXP THER, V277, P423

[7]

LOFBERG R, 1993, ALIMENT PHARM THERAP, V7, P611

[8]

RYRFELDT A, 1982, EUR J RESPIR DIS, V63, P86

[9] Colon-specific delivery of budesonide with azopolymer-coated pellets: Therapeutic effects of budesonide with a novel dosage form against 2,4,6-trinitrobenzenesulphonic acid-induced colitis in rats [J].

Tozaki, H ;

Fujita, T ;

Komoike, J ;

Kim, SI ;

Terashima, H ;

Muranishi, S ;

Okabe, S ;

Yamamoto, A .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1999, 51 (03) :257-261

[10] Clinically effective HIV-1 protease inhibitors [J].

Vacca, JP ;

Condra, JH .

DRUG DISCOVERY TODAY, 1997, 2 (07) :261-272

← 1 →